Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RLYB | Common Stock | Other | +2.33M | 2.33M | Jul 28, 2021 | Canaan XI L.P. | F1, F2 | |||
transaction | RLYB | Common Stock | Purchase | $1M | +76.9K | +3.3% | $13.00 | 2.41M | Aug 2, 2021 | Canaan XI L.P. | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RLYB | Series A-1 Preferred Units | Other | -1.8M | -100% | 0 | Jul 28, 2021 | Common Stock | 282K | Canaan XI L.P. | F1, F2, F3 | |||
transaction | RLYB | Series A-2 Preferred Units | Other | -8.74M | -100% | 0 | Jul 28, 2021 | Common Stock | 1.37M | Canaan XI L.P. | F1, F2, F3 | |||
transaction | RLYB | Series B Preferred Units | Other | -4.32M | -100% | 0 | Jul 28, 2021 | Common Stock | 678K | Canaan XI L.P. | F1, F2, F3 | |||
transaction | RLYB | Option (Right to Buy) | Award | $0 | +13.4K | $0.00 | 13.4K | Jul 28, 2021 | Common Stock | 13.4K | $13.00 | Direct | F4 |
Id | Content |
---|---|
F1 | The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the "Preferred Units") reported herein were preferred units of Rallybio Holdings, LLC. The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the "Plan of Liquidation"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation. |
F2 | The reported securities are held directly by Canaan XI L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC ("Canaan XI", and together with the Canaan Fund, the "Canaan Entities"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI. |
F3 | Prior to the effectiveness of the Plan of Liquidation, the Preferred Units were convertible into shares of common units of Rallybio Holdings, LLC. |
F4 | The option vests as to the underlying shares of Common Stock on the earlier of July 28, 2022 and the date of the first annual meeting of stockholders of the Issuer following the closing of its initial public offering. The option expires on July 28, 2031. |